Lumos Pharma, Inc. (LUMO)
NASDAQ: LUMO · IEX Real-Time Price · USD
1.460
+0.010 (0.69%)
At close: Jul 19, 2024, 4:00 PM
1.430
-0.030 (-2.05%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Lumos Pharma Stock Forecast
LUMO's stock price has decreased by -54.38% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Lumos Pharma stock have an average target of 18, with a low estimate of 10 and a high estimate of 28. The average target predicts an increase of 1,132.88% from the current stock price of 1.46.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 20, 2024.
Analyst Ratings
The average analyst rating for Lumos Pharma stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +1,817.81% | Mar 20, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $16 | Buy | Maintains | $16 | +995.89% | Mar 8, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +1,817.81% | Mar 8, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $17 → $16 | Buy | Maintains | $17 → $16 | +995.89% | Dec 11, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +1,817.81% | Dec 7, 2023 |
Financial Forecast
Revenue This Year
14.40M
from 2.05M
Increased by 602.29%
Revenue Next Year
680.00K
from 14.40M
Decreased by -95.28%
EPS This Year
-2.99
from -4.18
EPS Next Year
-1.89
from -2.99
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 42.2M | 2.1M | 13.1M | 202.1M | 335.2M |
| Avg | 14.4M | 680,003 | 6.3M | 98.2M | 171.0M |
| Low | 161,700 | n/a | n/a | n/a | 15.7M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 1,958.0% | -85.4% | 1,819.1% | 3,088.7% | 241.4% |
| Avg | 602.3% | -95.3% | 832.2% | 1,448.8% | 74.2% |
| Low | -92.1% | - | - | - | -84.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -2.08 | -1.09 | -1.08 | 8.12 | 14.70 |
| Avg | -2.99 | -1.89 | -1.20 | 7.88 | 14.28 |
| Low | -3.49 | -2.51 | -1.30 | 7.58 | 13.72 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 86.4% |
| Avg | - | - | - | - | 81.1% |
| Low | - | - | - | - | 74.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.